Institutional
August 9, 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Last related news
December 13, 2024
We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
We present you KL Index, a tool that easily provides historical data to analyze the growth of Intellectual Property (IP) in the … We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
December 6, 2024
Tarso Machado participates in FICPI’s webinar as a Rising IP Star
Our partner Tarso Machado will participate in the international webinar “Rising IP Stars”, promoted by FICPI – International Federation of Intellectual Property … Tarso Machado participates in FICPI’s webinar as a Rising IP Star
November 28, 2024
We are ranked on Análise Advocacia 2025
We are honored to announce that we have been ranked by Análise Advocacia – 2025 Edition among the most admired firms in … We are ranked on Análise Advocacia 2025